Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Cash flows from (used in) operating activities
Net loss	$ (2,585)	$ (3,041)	$ (4,157)	$ (3,852)
Adjustments to reconcile net loss to net cash from operating activities:
Stock-based compensation			3,296	1,661
Depreciation and amortization			2,018	513
Inventory step-up			2,349	0
Non-cash lease expense			30	36
Debt discount amortization and non-cash interest expenses			342	48
Changes in operating assets and liabilities:
Accounts receivable			(9,092)	(1,462)
Inventories			(10,909)	(1,157)
Prepaid expenses and other assets			672	330
Accounts payable			7,970	284
Accrued Medicaid rebates			9,359	3,514
Accrued liabilities			(1,201)	(1,133)
Other non-current assets and liabilities			9,372	0
Net cash from (used in) operating activities			10,049	(1,218)
Cash flows from (used in) investing activities
Purchases of product license rights			0	(1,868)
Purchases of property and equipment			0	(14)
Net cash from (used in) investing activities			0	(1,882)
Cash flows from (used in) financing activities
Repayment of long-term debt			0	(770)
Proceeds from employee stock purchase plan and stock option exercises			394	176
Net cash from (used in) financing activities			394	(594)
Change in cash and cash equivalents			10,443	(3,694)
Cash and cash equivalents at beginning of period			14,936	21,388	$ 21,388
Cash and cash equivalents at end of period	$ 25,379	$ 17,694	25,379	17,694	$ 14,936
Supplemental disclosures of cash flow information
Cash paid for interest			852	362
Cash paid for income taxes			$ 89	$ 0